Expert Interview
Discussing Boehringer's nerandomilast in Idiopathic Pulmonary Fibrosis (IPF) following the publication in NEJM
Ticker(s): BOEHRINGER INGELHEIM, RHHBYInstitution: National Jewish Health
- Associate Professor of Pulmonary Sciences & Director of Interstitial Lung Disease program at National Jewish Health
- Manages 80 patients with IPF.
- Research focuses on Interstitial Lung Diseases and specifically on those related to autoimmune diseases.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
